Sanne Weijzen

Sanne Weijzen is a biomedical venture capital professional and former Chief Operating Officer currently based in Bilthoven, Netherlands, possessing extensive expertise in early-stage life sciences investments. She began her investment career at Aglaia BioMedical Ventures, advancing from a Business Analyst to a Partner and serving as a director of Aglaia Management until stepping down in February 2014. Transitioning into executive operational roles, Weijzen previously operated as the Chief Operating Officer at Scenic Biotech, an early-stage life sciences company, and has been associated with organizational structures involving the pharmaceutical corporation AstraZeneca. She holds a Master's degree and a doctorate in Biomedical Sciences, applying her academic expertise to evaluate and scale early-stage therapeutics. Her professional background centers on advancing early-stage life sciences investments, with a specific focus on identifying commercial opportunities within the oncology and cell therapy sectors.